Visionary product leader with deep benefits administration expertise joins to deliver innovative products and services Eddie ...
LOS ALTOS, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UNCY), a clinical-stage biotechnology company developing ...
Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...